by betvmsibg | Mar 12, 2026 | Boosting Employee Retention, Employee Wellness, Health Plan Costs, Health Plan Design, Public Sector Benefits, Supplemental Benefits, Uncategorized
As organizations move deeper into 2026, many employers are taking a closer look at their workforce data after the traditional first-quarter wave of job changes. While the “Great Resignation” headlines have softened, turnover remains a persistent challenge across many...
by betvmsibg | Feb 25, 2026 | Drug Costs, Employee Benefits Education, Health Plan Costs, Health Plan Design, Pharmacy Benefit Managers (PBMs)
Pharmacy costs continue to outpace nearly every other component of employer health plan spending. Specialty drugs, rebate structures, formulary shifts, and limited contract visibility have created frustration for many plan sponsors. Now, a new name has entered the...
by betvmsibg | Feb 12, 2026 | Boosting Employee Retention, Employee Wellness, Health Plan Costs, Health Plan Design, Public Sector Benefits, Supplemental Benefits
Fresh ideas for companies evaluating new care delivery models early in the year As employers look ahead to a new year, many are asking the same question they ask every renewal season: how can we deliver better healthcare experiences for employees while keeping costs...
by betvmsibg | Jan 27, 2026 | Drug Costs, Health Plan Costs, Health Plan Design, Pharmacy Benefit Managers (PBMs), Public Sector Benefits
Specialty drugs represent one of the fastest-growing cost drivers in employer-sponsored health plans. While these medications often account for a small percentage of total prescriptions, they can consume 40–60% of total pharmacy spend. For self-funded employers,...
by betvmsibg | Jan 15, 2026 | Data Analytics, Drug Costs, Health Plan Costs, Health Plan Design, Mental Health Compliance, Pharmacy Benefit Managers (PBMs), Public Sector Benefits, Supplemental Benefits
As we settle into 2026, employer-sponsored health plans face a compliance landscape that’s both richer in transparency and denser in requirements. Among the most talked-about and consequential mandates is Prescription Drug Data Collection (RxDC) reporting under the...
